EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management

Anna Koumarianou, Jules Derks, Marina Tsoli, Marco Volante iD, Lynnette Fernandez-Cuesta iD, Vikas Prasad, Pier Luigi Filosso, Benjamin Gibert, Thomas Walter iD, Alice Durand

Endocrine Reviews · 13.05.2026 · 47 (3) · 351-374

DOI: 10.1210/endrev/bnag001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine Reviews, online erschienen am 12.01.2026. Verfasst von Anna Koumarianou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Oncology Unit, Fourth Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University o…. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoid Tumor, Neuroendocrine Tumors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 178 Literaturangaben. Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This narrative review aims to provide a comprehensive synthesis of current knowledge and guidelines on lung carcinoids, emphasizing the multidimensional approach required for effective diagnosis and management. The manuscript will: (i) define and classify lung carcinoids in accordance with the latest WHO classification system, and emphasize the importance of molecular markers for precise subtyping; (ii) analyze epidemiological trends, discuss prevalence, incidence, and mortality rates, alongside key risk factors including genetic predispositions (MEN1) and precursor lesions such as diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH); (iii) investigate the etiology and carcinogenesis of lung carcinoids, including insights into the molecular hallmarks and pathways that underlie tumor development and progression; (iv) detail clinical presentations, distinguishing pulmonary symptoms from secretory syndromes (carcinoid syndrome and Cushing syndrome), supported by visual aids to elucidate symptom prevalence and implications; (v) present an integrated diagnostic approach, encompassing state-of-the-art imaging modalities (CT, magnetic resonance imaging [MRI], 68Ga-SSA-positron emission tomography [PET]-CT) and advanced molecular pathology techniques; (vi) outline evidence-based treatment strategies, addressing early-stage interventions, systemic therapies, locoregional therapies, and emerging modalities such as immunotherapy and agnostic approaches; (vii) explore the role of multidisciplinary management, highlighting the critical importance of tumor boards dedicated to lung carcinoids and provide a checklist of key items for comprehensive case discussion and decision-making; and (viii) conclude with future perspectives, identifying gaps in current knowledge and suggest directions for research to enhance diagnosis, treatment, and overall patient quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoid TumorNeuroendocrine TumorsHumans

Stichwörter der Autor:innen

carcinoidslungmanagementneuroendocrine tumorsprognosistreatment

Autor:innen und Institutionen

  • Hematology Oncology Unit, Fourth Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens 12462, Greece.
  • Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, 3015 CP, Rotterdam, Netherlands.
  • 1st Department of Propaedeutic and Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, Athens 11527, Greece.
  • Department of Oncology, University of Turin at San Luigi Hospital, 10126 Torino, Italy.
  • Computational Cancer Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), 69366 Lyon, France.
  • Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110, USA.

ORCID-Profile: Marco Volante, Lynnette Fernandez-Cuesta, Thomas Walter

Förderung

  • World Health Organization

Zitieren

APA

Koumarianou, A., Derks, J., Tsoli, M., Volante, M., Fernandez-Cuesta, L., Prasad, V., Filosso, P. L., Gibert, B., Walter, T., & Durand, A. (2026). Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management. Endocrine Reviews, 47(3), 351-374. https://doi.org/10.1210/endrev/bnag001

Vancouver

Koumarianou A, Derks J, Tsoli M, Volante M, Fernandez-Cuesta L, Prasad V, et al. Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management. Endocrine Reviews. 2026;47(3):351-374. doi:10.1210/endrev/bnag001

BibTeX
@article{Koumarianou2026,
  author = {Koumarianou, Anna and Derks, Jules and Tsoli, Marina and Volante, Marco and Fernandez-Cuesta, Lynnette and Prasad, Vikas and Filosso, Pier Luigi and Gibert, Benjamin and Walter, Thomas and Durand, Alice},
  title = {Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management},
  journal = {Endocrine Reviews},
  year = {2026},
  volume = {47},
  number = {3},
  pages = {351--374},
  doi = {10.1210/endrev/bnag001}
}
Kostenlos starten →